Related Experiment Video
Updated: May 3, 2026

In Vivo Imaging of Cerebrospinal Fluid Transport through the Intact Mouse Skull using Fluorescence Macroscopy
Published on: July 29, 2019
Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter Hyperintensity
Abstract:
White matter hyperintensity (WMH) represents a critical global medical concern linked to cognitive decline and dementia, yet its underlying mechanisms remain poorly understood. Here, humans are directly demonstrated that high WMH burden correlates with delayed drainage of meningeal lymphatic vessels (mLVs) and glymphatic pathway. Additionally, a longitudinal cohort study reveals that glymphatic dysfunction predicts WMH progression. Next, in a rat model of WMH, the presence of impaired lymphangiogenesis and glymphatic drainage is confirmed, followed by elevated microglial activation and white matter demyelination. Notably, enhancing meningeal lymphangiogenesis through adeno-associated virus delivery of vascular endothelial growth factor-C (VEGF-C) mitigates microglial gliosis and white matter demyelination. Conversely, blocking the growth of mLVs with a VEGF-C trap strategy exacerbates these changes. The findings highlight the role of mLVs and glymphatic pathway dysfunction in aggravating brain white matter injury, providing a potential novel strategy for WMH prevention and treatment.
Insights
White matter hyperintensity (WMH) is linked to cognitive decline. Impaired lymphatic drainage exacerbates WMH, but enhancing meningeal lymphangiogenesis may offer a new treatment strategy.
Area of Science:
- Neuroscience
- Vascular Biology
- Immunology
Background:
- White matter hyperintensity (WMH) is a significant concern associated with cognitive decline and dementia.
- The precise mechanisms driving WMH progression remain largely unknown.
- Dysfunction in brain clearance pathways, including meningeal lymphatics and the glymphatic system, is implicated.
Purpose of the Study:
- To investigate the relationship between WMH burden and the function of meningeal lymphatic vessels (mLVs) and the glymphatic pathway.
- To explore the role of lymphangiogenesis and glymphatic drainage in WMH pathogenesis using a rat model.
- To evaluate the therapeutic potential of modulating mLVs for WMH treatment.
Main Methods:
- Human studies correlating WMH burden with mLV and glymphatic drainage.
- Longitudinal cohort analysis of glymphatic function and WMH progression.
- Rat model of WMH to assess lymphangiogenesis, glymphatic drainage, microglial activation, and demyelination.
- Intervention using adeno-associated virus (AAV)-mediated VEGF-C delivery to enhance mLVs.
- VEGF-C trap strategy to inhibit mLV growth.
Main Results:
- High WMH burden in humans is associated with delayed mLV and glymphatic drainage.
- Glymphatic dysfunction predicts future WMH progression.
- WMH model in rats showed impaired lymphangiogenesis, reduced glymphatic drainage, increased microglial activation, and demyelination.
- Enhancing mLVs with AAV-VEGF-C reduced gliosis and demyelination.
- Inhibiting mLVs exacerbated WMH pathology.
Conclusions:
- Dysfunction of mLVs and the glymphatic pathway plays a crucial role in the progression of brain white matter injury.
- Modulating meningeal lymphangiogenesis presents a promising therapeutic avenue for preventing and treating WMH.
More Related Videos
10:05Three-Dimensional Imaging of the Vertebral Lymphatic Vasculature and Drainage using iDISCO+ and Light Sheet Fluorescence Microscopy
Published on: May 22, 2020
09:35Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Related Concept Videos
The Blood-brain Barrier
Diabetic Neuropathy
Bacterial Meningitis II: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology